<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mavromoustakos, T.</style></author><author><style face="normal" font="default" size="100%">Theodoropoulou, E.</style></author><author><style face="normal" font="default" size="100%">Matsoukas, J.</style></author><author><style face="normal" font="default" size="100%">Moore, G.</style></author><author><style face="normal" font="default" size="100%">Smith, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Use of molecular modeling to study superimposition of angiotensin II with its non-peptide receptor antagonists</style></title><secondary-title><style face="normal" font="default" size="100%">Review of Clinical Pharmacology and Pharmacokinetics, International Edition</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">1994</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1994</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028686709&amp;partnerID=40&amp;md5=f99d4c0bfb366ced6e6d4f3366f0860a</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">137 - 142</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">3</style></issue><notes><style face="normal" font="default" size="100%">Cited By :1Export Date: 23 August 2017</style></notes></record></records></xml>